FDA Public Meeting Report on "Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications".

Authors

Mohammad Akbar
Erin Berry-Bibee
Diana L Blithe
Ruth S Day
Alison Edelman
Joachim Höchel
Roxanne Jamshidi, George Washington University
Myong-Jin Kim
Li Li
Vivek S Purohit
Jim A Turpin
Pamela E Scott
David G Strauss
Haiying Sun
Naomi K Tepper
Lei Zhang
Chongwoo Yu

Document Type

Journal Article

Publication Date

8-24-2018

Journal

Journal of clinical pharmacology

DOI

10.1002/jcph.1285

Comments

epub ahead of print

APA Citation

Akbar, M., Berry-Bibee, E., Blithe, D., Day, R., Edelman, A., Höchel, J., Jamshidi, R., Kim, M., Li, L., Purohit, V., Turpin, J., Scott, P., Strauss, D., Sun, H., Tepper, N., Zhang, L., & Yu, C. (2018). FDA Public Meeting Report on "Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications".. Journal of clinical pharmacology, (). http://dx.doi.org/10.1002/jcph.1285

Peer Reviewed

1